News

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hani Kushlaf, MD, FAAN, FANA, FAANEM, at the University of Cincinnati Gardner Neuroscience Institute in Cincinnati, Ohio, as a ...

A newly published study led by CMTA’s Strategy to Accelerate Research (CMTA-STAR) Clinical Expert Board Co-Chair Professor Mary M. Reilly, MBE, MD, and colleagues explores how MRI can track disease progression in CMT1A and serve as a potential biomarker for ...

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hernan Gonorazky, MD, at The Hospital for Sick Children (SickKids) in Toronto, Ontario, as a CMTA Center of Excellence. Dr. ...

Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease (CMT). Led by Andrea Cortese, MD, PhD, at University College London, this new CMTA Strategy To Accelerate Research ...

An international team of researchers from the Inherited Neuropathies Consortium (INC), led by CMTA’s Strategy To Accelerate Research (CMTA-STAR) Advisory Board Member Michael Shy, MD, at the University of Iowa, has successfully reached full enrollment for INC’s CMT2F Natural History ...